Home
About
Overview
Sharing Data
ORCID
Help
History (17)
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Complications of peristomal recurrence of Crohn's disease: a case report and a review of literature.
Superficial doses in treatment of breast with tangential fields using 4MV x-rays.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Superficial doses in treatment of breast with tangential fields using 4MV x-rays.
Superficial doses in treatment of breast with tangential fields using 4MV x-rays. Int J Radiat Oncol Biol Phys. 1977 Jul-Aug; 2(7-8):705-10.
View in:
PubMed
subject areas
Breast Neoplasms
Female
Humans
Mathematics
Radiotherapy Dosage
Radiotherapy, High-Energy
Skin
authors with profiles
Ralph R. Weichselbaum